Browse 127 Cirrhosis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Cirrhosis is a late-stage liver disease in which the liver becomes severely scarred due to prolonged liver damage from causes like hepatitis, alcohol abuse, or fatty liver disease.
Clinical trials for cirrhosis explore innovative treatments aimed at slowing liver damage and improving liver function, offering participants access to the latest therapies designed to help manage their condition and improve liver health.
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for
Primary Biliary Cholangitis
Location: Boston MA, Quebec, New York NY, Manhasset NY, Montreal,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06051617
Phase3, Recruiting
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
for
Metastatic Colorectal Cancer (Mcrc),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05286814
Phase2, Recruiting
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)